Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Nursing care needs and services utilised by home-dwelling elderly with complex health problems: observational study.

Næss G, Kirkevold M, Hammer W, Straand J, Wyller TB.

BMC Health Serv Res. 2017 Sep 12;17(1):645. doi: 10.1186/s12913-017-2600-x.

2.
3.

Integrative fascial release and functional testing.

Hammer W.

Australas Chiropr Osteopathy. 2000 Mar;9(1):13-6.

4.

[Recommendations for keeping birds of prey and owls according to animal welfare regulations].

Hammer W, Heidenreich M, Kösters J, Trommer G.

Tierarztl Prax. 1989;17(1):59-70. Review. German.

PMID:
2655173
5.

[Requirements, disease and accident hazards at the work site in animal production].

Hammer W.

Zentralbl Arbeitsmed Arbeitsschutz Prophyl. 1977 Jul;27(7):157-64. German. No abstract available.

PMID:
899320
6.

[Biomechanic behavior, muscle reaction and subjective perception under vibration stress of the upper extremities between 8 and 80 Hz (author's transl)].

Dupuis H, Hartung E, Hammer W.

Int Arch Occup Environ Health. 1976 Apr 28;37(1):9-34. German. No abstract available.

PMID:
1262070
7.

Influence of dihydroergotamine on the lipolytic system of isolated dog fat cells.

Vogel-Chevalier L, Hammer W, Flückiger E.

Experientia. 1971 Jun;27(6):674-6. No abstract available.

PMID:
4326617
8.

[Drug interaction: lethal interaction between nialamide and blue-veined cheese].

Hammer W, Holmberg G, Sjöqvist F, Wiklund PE.

Lakartidningen. 1969 Dec 15;66:Suppl IV:20+. Swedish. No abstract available.

PMID:
5400771
9.

The pH-dependent excretion of monomethylated tricyclic antidepressants.

Sjöqvist F, Berglund F, Borgå O, Hammer W, Andersson S, Thorstrand C.

Clin Pharmacol Ther. 1969 Nov-Dec;10(6):826-33. No abstract available.

PMID:
5349623
10.

The metabolism of tremorine--the identification of 1,4-di (2-oxopyrrolidino)-2-butyne (symmetric dioxotremorine).

Hammar CG, Hammer W, Holmstedt B, Karlén B, Sjöqvist F, Vessman J.

Biochem Pharmacol. 1969 Jul;18(7):1549-51. No abstract available.

PMID:
5806100
11.

A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man.

Hammer W, Mårtens S, Sjöqvist F.

Clin Pharmacol Ther. 1969 Jan-Feb;10(1):44-9. No abstract available.

PMID:
5765184
12.

The metabolism of tremorine. Identification of a new biologically active metabolite, N-(4-pyrrolidino-2-2-butynyl)-gamma-aminobutyric acid.

Hammer W, Holmstedt B, Karlén B, Sjöqvist F, Vessman J.

Biochem Pharmacol. 1968 Sep;17(9):1931-41. No abstract available.

PMID:
5699792
13.

The influence of body temperature on the elimination of oxotremorine in the mouse.

Hammer W, Karlén B, Sjöqvist F.

Biochem Pharmacol. 1968 Jun;17(6):935-44. No abstract available.

PMID:
5661355
14.

[The effect of desmethylimipramine and other "anti-tremorine" drugs on the metabolism of tremorine and oxotremorine in rats and mice].

Sjöqvist F, Hammer W, Schumacher H, Gillette J.

Biochem Pharmacol. 1968 Jun;17(6):915-34. No abstract available.

PMID:
5661354
15.

Application of steady-state kinetics to the uptake and decline of H3-NE in the rat heart.

Neff NH, Tozer TN, Hammer W, Costa E, Brodie BB.

J Pharmacol Exp Ther. 1968 Mar;160(1):48-52. No abstract available.

PMID:
5639110
16.

Drug-induced changes in brain levels of oxotremorine in mice.

Hammer W, Karlén B, Sjöqvist F.

Life Sci. 1968 Feb 1;7(3):205-11. No abstract available.

PMID:
5644535
17.

Rate of metabolism of tremorine and oxotremorine in rats and mice.

Hammer W, Karlén B, Rane A, Sjöqvist F.

Life Sci. 1968 Feb 1;7(3):197-204. No abstract available.

PMID:
5639819
18.

Oxotremorine and central monoamine neurons.

Corrodi H, Fuxe K, Hammer W, Sjöqvist F, Ungerstedt U.

Life Sci. 1967 Dec 1;6(23):2557-66. No abstract available.

PMID:
6080575
19.

Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Hammer W, Sjöqvist F.

Life Sci. 1967 Sep 1;6(17):1895-903. No abstract available.

PMID:
6052684
20.

Excessively growing monoamine-containing nerves in mice during treatment with a nerve growth factor (NGF).

Hammer W, Norberg KA, Olson L, Sjöqvist F.

Acta Physiol Scand. 1967 Jan-Feb;69(1):127-8. No abstract available.

PMID:
6031388

Supplemental Content

Loading ...
Support Center